News
20h
News-Medical.Net on MSNWatch: How the FDA opens the door to risky chemicals in America’s food supplyIn 1958, Congress mandated that before additives could be used in foods manufacturers had to prove they were safe and get FDA ...
GlobalData on MSN15h
FDA plans to expand unannounced inspections of foreign drug plantsThis move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.
20h
GlobalData on MSNSarepta shares fall amid FDA’s CBER appointment and weak Elevidys salesSarepta’s stock dropped by 26% after the FDA named a vocal critic of its gene therapy programme to lead its biologics ...
MEDIPAL and JCR announced that the U.S. FDA granted orphan drug designation (ODD) to JR-446, an investigational drug for the ...
DUBLIN, May 07, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced its financial ...
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
A team of pioneering physicians at a renowned medical center has requested to validate the INSPIRA ART100 system for application in highly complex organ transplant procedures. This deployment will ...
The initial POC results, presented April 26, 2025 at the Annual ELITE PED-GI Congress, show crofelemer reduced the required total parenteral nutrition (TPN) and/or supplementary intravenous fluids, ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, May 7, 2025 (HealthDay News) -- The use of nicotine pouches nearly doubled ...
Announced U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the treatment of hyperphagia in adults and ...
The benefits of adding seaweed to the diets of cows confined to barns is well studied, but feeding it to cattle scattered on ...
Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results